Anti-Tac (90Y-HAT)

90Y-labeled anti-Tac monoclonal antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-Tac (90Y-HAT), covering 2015-12-07 to 2015-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia [Phase 1, Phase 2]